FibroBiologics Inc. (NASDAQ: FBLG)
$5.32
+0.3150 ( +6.30% ) 132.5K
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Market Data
Open
$5.32
Previous close
$5.00
Volume
132.5K
Market cap
$189.67M
Day range
$4.93 - $5.42
52 week range
$3.90 - $55.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Jul 08, 2024 |
def | Proxies and info statements | 5 | Jul 08, 2024 |
pre | Proxies and info statements | 5 | Jun 27, 2024 |
8-k | 8K-related | 15 | Jun 27, 2024 |
10-q | Quarterly Reports | 61 | May 14, 2024 |
8-k | 8K-related | 17 | Apr 26, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
3 | Insider transactions | 1 | Mar 06, 2024 |
10-k | Annual reports | 83 | Feb 29, 2024 |
8-k | 8K-related | 16 | Feb 20, 2024 |